IL107838A0 - Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing them - Google Patents
Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL107838A0 IL107838A0 IL10783893A IL10783893A IL107838A0 IL 107838 A0 IL107838 A0 IL 107838A0 IL 10783893 A IL10783893 A IL 10783893A IL 10783893 A IL10783893 A IL 10783893A IL 107838 A0 IL107838 A0 IL 107838A0
- Authority
- IL
- Israel
- Prior art keywords
- antagonists
- preparation
- pharmaceutical compositions
- compositions containing
- compounds useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929225396A GB9225396D0 (en) | 1992-12-04 | 1992-12-04 | Improvements in or relating to organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL107838A0 true IL107838A0 (en) | 1994-04-12 |
Family
ID=10726140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10783893A IL107838A0 (en) | 1992-12-04 | 1993-12-02 | Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0606044A1 (cs) |
| JP (1) | JPH06228122A (cs) |
| KR (1) | KR940014377A (cs) |
| CN (1) | CN1095417A (cs) |
| AU (1) | AU5211293A (cs) |
| CA (1) | CA2110553A1 (cs) |
| CZ (1) | CZ261493A3 (cs) |
| FI (1) | FI935409A7 (cs) |
| GB (1) | GB9225396D0 (cs) |
| HU (1) | HUT65910A (cs) |
| IL (1) | IL107838A0 (cs) |
| MX (1) | MX9307608A (cs) |
| NO (1) | NO934372L (cs) |
| NZ (1) | NZ250344A (cs) |
| PL (1) | PL301281A1 (cs) |
| SK (1) | SK135493A3 (cs) |
| TW (1) | TW258736B (cs) |
| ZA (1) | ZA939088B (cs) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4228328C2 (de) * | 1992-08-26 | 1999-02-11 | Agie Sa | Maschine und Verfahren zum funkenerosiven Drahtschneiden mit einer im Querschnitt verformten Drahtelektrode |
| US5795910A (en) * | 1994-10-28 | 1998-08-18 | Cor Therapeutics, Inc. | Method and compositions for inhibiting protein kinases |
| US5731343A (en) * | 1995-02-24 | 1998-03-24 | The Scripps Research Institute | Method of use of radicicol for treatment of immunopathological disorders |
| ES2149468T3 (es) * | 1995-04-26 | 2000-11-01 | Kyowa Hakko Kogyo Kk | Derivados de radicicol. |
| WO2000038674A1 (en) * | 1998-12-24 | 2000-07-06 | Novation Pharmaceuticals Inc. | COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |
| WO2002016369A2 (en) | 2000-08-25 | 2002-02-28 | Sloan-Kettering Institute For Cancer Research | Novel macrocycles and uses thereof |
| JP2004292314A (ja) * | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
| JP2004292315A (ja) * | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | Ｔａｋ１阻害剤 |
| GB0112522D0 (en) * | 2001-05-23 | 2001-07-11 | Ici Plc | Catalytic process |
| US7915306B2 (en) * | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| KR101210018B1 (ko) * | 2002-03-08 | 2012-12-07 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 약물로서 유용한 거대고리 화합물 |
| JPWO2003086334A1 (ja) * | 2002-04-17 | 2005-08-18 | 大正製薬株式会社 | 育毛剤 |
| US20060079494A1 (en) * | 2004-09-27 | 2006-04-13 | Santi Daniel V | Specific kinase inhibitors |
| US7601852B2 (en) | 2006-05-11 | 2009-10-13 | Kosan Biosciences Incorporated | Macrocyclic kinase inhibitors |
| KR101573026B1 (ko) | 2007-07-25 | 2015-11-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 암 치료에서 이용하기 위한 멀티키나아제 억제제 |
| AU2008318690B2 (en) | 2007-10-29 | 2015-08-13 | Eisai R & D Management Co., Ltd. | Methods for prognosing the ability of a zearalenone analog compound to treat cancer |
| JP5492786B2 (ja) | 2007-12-07 | 2014-05-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ゼラレノンマクロライドアナログを作製するための中間体および方法 |
| JP6265583B2 (ja) | 2008-10-17 | 2018-01-24 | ウィスコンシン アルムニ リサーチ ファンデイション | 生理活性アルファベータペプチドを作製する方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3196019A (en) * | 1964-04-06 | 1965-07-20 | Purdue Research Foundation | Anabolic and estrogenic compound and process of making |
-
1992
- 1992-12-04 GB GB929225396A patent/GB9225396D0/en active Pending
-
1993
- 1993-11-29 EP EP93810835A patent/EP0606044A1/en not_active Withdrawn
- 1993-12-02 CZ CZ932614A patent/CZ261493A3/cs unknown
- 1993-12-02 AU AU52112/93A patent/AU5211293A/en not_active Abandoned
- 1993-12-02 PL PL93301281A patent/PL301281A1/xx unknown
- 1993-12-02 MX MX9307608A patent/MX9307608A/es unknown
- 1993-12-02 NZ NZ250344A patent/NZ250344A/en unknown
- 1993-12-02 SK SK1354-93A patent/SK135493A3/sk unknown
- 1993-12-02 IL IL10783893A patent/IL107838A0/xx unknown
- 1993-12-02 NO NO934372A patent/NO934372L/no unknown
- 1993-12-02 CA CA002110553A patent/CA2110553A1/en not_active Abandoned
- 1993-12-02 FI FI935409A patent/FI935409A7/fi not_active Application Discontinuation
- 1993-12-03 ZA ZA939088A patent/ZA939088B/xx unknown
- 1993-12-03 KR KR1019930026567A patent/KR940014377A/ko not_active Withdrawn
- 1993-12-03 CN CN93120777A patent/CN1095417A/zh active Pending
- 1993-12-03 HU HU9303444A patent/HUT65910A/hu unknown
- 1993-12-03 JP JP5303866A patent/JPH06228122A/ja active Pending
- 1993-12-06 TW TW082110279A patent/TW258736B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| CN1095417A (zh) | 1994-11-23 |
| CA2110553A1 (en) | 1994-06-05 |
| NO934372D0 (no) | 1993-12-02 |
| HU9303444D0 (en) | 1994-04-28 |
| EP0606044A1 (en) | 1994-07-13 |
| FI935409L (fi) | 1994-06-05 |
| ZA939088B (en) | 1995-06-05 |
| GB9225396D0 (en) | 1993-01-27 |
| NZ250344A (en) | 1995-10-26 |
| KR940014377A (ko) | 1994-07-18 |
| FI935409A0 (fi) | 1993-12-02 |
| NO934372L (no) | 1994-06-06 |
| MX9307608A (es) | 1995-01-31 |
| PL301281A1 (en) | 1994-06-13 |
| SK135493A3 (en) | 1994-08-10 |
| FI935409A7 (fi) | 1994-06-05 |
| CZ261493A3 (en) | 1994-07-13 |
| HUT65910A (en) | 1994-07-28 |
| TW258736B (cs) | 1995-10-01 |
| AU5211293A (en) | 1994-06-16 |
| JPH06228122A (ja) | 1994-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL107838A0 (en) | Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing them | |
| IL111627A0 (en) | Substituted phenylpyrimidine compounds, their preparation and pharmaceutical compositions containing them | |
| HUT66324A (en) | Quinazoline derivatives as acetylcholinesterase inhibitors and pharmaceutical compositions containing them | |
| IL102638A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL103053A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL106353A0 (en) | Unsymmetrical mono-3-nitro-bis-naphthalimides,their preparation and pharmaceutical compositions containing them | |
| HUT70544A (en) | Heteroaryl-amines as acetyl-cholinesterase inhibitors, pharmaceutical compositions comprising them and process for their preparation | |
| IL101380A0 (en) | Bis-naphthalimides,their preparation and pharmaceutical compositions containing them | |
| HUP0000678A3 (en) | Aminobenzophenones as inhibitors of interleukin and tnf, process for their preparation and pharmaceutical compositions containing the same | |
| IL103757A (en) | Oligodeoxyribonucleotides their preparation and pharmaceutical compositions containing them | |
| IL106408A0 (en) | Benzimidazoles,their preparation and pharmaceutical compositions containing them | |
| EP0499416A3 (en) | Pyridine compounds as angiotensin ii antagonists, processes for their preparation and pharmaceutical compositions containing them | |
| HUP9900071A3 (en) | Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use | |
| IL104099A0 (en) | Imidazoquinazoline compounds,their preparation and pharmaceutical compositions containing them | |
| IL108073A0 (en) | Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them | |
| IL105356A0 (en) | Benzimidazoles,their preparation and pharmaceutical compositions containing them | |
| IL106385A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL87600A0 (en) | Hmg-coa reductase inhibitors,their preparation and pharmaceutical compositions containing them | |
| IL104042A0 (en) | Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them | |
| ZA933426B (en) | New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them | |
| IL106041A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL105774A0 (en) | Thienothiazine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL89155A0 (en) | Ouabain-like compounds and pharmaceutical compositions containing them | |
| IL104347A0 (en) | Substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL101164A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them |